CoChat

CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Purpose: Choroideremia (CHM) is a rare inherited retinal degeneration resulting from mutation of the CHM gene, which results in absence of functional Rab escort protein 1 (REP1). We evaluated retinal gene therapy with an adeno-associated virus vector that used to deliver a functional version of the CHM gene (AAV2-REP1). Methods: THOR (NCT02671539) is a Phase 2, open-label, single-center, randomized study. Six male patients (51–60 years) with CHM received AAV2-REP1, by a single 0.1-mL subretinal injection of 10 11 genome particles during vitrectomy. Twelve-month data are reported. Results: In study eyes, 4 patients experienced minor changes in best-corrected visual acuity (−4 to +1 Early Treatment Diabetic Retinopathy Study [ETDRS] letters); one gained 17 letters and another lost 14 letters. Control eyes had changes of −2 to +4 letters. In 5/6 patients, improvements in mean (95% confidence intervals) retinal sensitivity (2.3 [4.0] dB), peak retinal sensitivity (2.8 [3.5] dB), and gaze fixation area (−36.1 [66.9] deg 2 ) were recorded. Changes in anatomical endpoints were similar between study and control eyes. Adverse events were consistent with the surgical procedure. Conclusion: Gene therapy with AAV2-REP1 can maintain, and in some cases, improve, visual acuity in CHM. Longer term follow-up is required to establish whether these benefits are maintained.

Overview

Integrity signals

Registry

Crossref · 10.1097/iae.0000000000002360

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 67

Metadata

Authors
Fischer, M. D., Ochakovski, G. A., Beier, B., Seitz, I. P., Vaheb, Y., Kortuem, C., Reichel, F. F. L., Kuehlewein, L., Kahle, N. A., Peters, T., Girach, A., Zrenner, E., Ueffing, M., MacLaren, R. E., Bartz-Schmidt, K., & Wilhelm, B.
Affiliations
  • University of Oxford (GB)
  • University of Tübingen (DE)
  • Universitätsklinikum Tübingen (DE)
  • Nightstar Therapeutics, London, United Kingdom;
  • Moorfields Eye Hospital NHS Foundation Trust (GB)
  • University Eye Hospital, Centre for Ophthalmology, Tübingen, Germany;
Corresponding author
  • Fischer, M. Dominik
  • Ochakovski, G. Alex
  • Seitz, Immanuel P.
  • Vaheb, Yousof
  • Kortuem, Constanze
  • Reichel, Felix F. L.
  • Kuehlewein, Laura
  • Zrenner, Eberhart
  • MacLaren, Robert E.
Venue
Retina
Published
2020-01
Volume
40
Issue
1
Pages
160-168
ISSN
0275-004X (ISSN-L)
OpenAlex
W2897506831
Cited by
66
References
23
Citations by year
2026: 5 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 11
FWCI
2.76
Type
journal article
Language
en
Open access
closed
Locations
  • Retina (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
choroideremia, retinal gene therapy, adeno-associated virus vectors, Rab escort protein 1, CHM gene, subretinal injection, visual acuity, retinal sensitivity, inherited retinal degeneration
MeSH terms
Dependovirus, Genetic Vectors, Humans, Male, Middle Aged, Retina, Visual Acuity, Visual Fields, Vitrectomy, Genetic Therapy, Choroideremia, Parvovirinae, Adaptor Proteins, Signal Transducing, Visual Field Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA. https://app.cochat.ai/papers/10.1097/iae.0000000000002360
The paper
Fischer, M. D., Ochakovski, G. A., Beier, B., Seitz, I. P., Vaheb, Y., Kortuem, C., Reichel, F. F. L., Kuehlewein, L., Kahle, N. A., Peters, T., Girach, A., Zrenner, E., Ueffing, M., MacLaren, R. E., Bartz-Schmidt, K., & Wilhelm, B. (2020). CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA. Retina. https://doi.org/10.1097/iae.0000000000002360

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.